Sweden· SE-20140716000049
Pulmozyme 1 mg/ml Lösning för nebulisator
A medicinal product containing dornase alfa, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Dornase Alfa
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140716000049
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dornase alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandPulmozymeRoche Pharmaceuticals A/S
- NetherlandsPulmozyme, inhalatievloeistof 1 mg/ml, 2,5 mlEU-Pharma B.V.
- FinlandPulmozymeRoche Oy
- PolandPulmozymeRoche Polska Sp. z o.o.
- United StatesPulmozymeGenentech, Inc.
- NorwayPulmozymeRoche Norge AS
- United KingdomPulmozyme 2.5mg nebuliser liquid 2.5ml ampoulesWaymade Healthcare Plc
- IrelandPulmozyme 2500 U/ 2.5ml, nebuliser solutionRoche Products (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Pulmozyme
- Belgium · Pulmozyme
- Bulgaria · Пулмозим
- Cyprus · Pulmozyme
- Czechia · Pulmozyme
- Germany · Pulmozyme
- Denmark · Pulmozyme
- Estonia · Pulmozyme
- Spain · Pulmozyme
- Finland · Pulmozyme
- France · Pulmozyme
- United Kingdom (Northern Ireland) · Pulmozyme
- Greece · Pulmozyme
- Croatia · Pulmozyme Otopina Za Atomizator
- Hungary · Pulmozyme
- Ireland · Pulmozyme
- Iceland · Pulmozyme
- Italy · Pulmozyme
- Lithuania · Pulmozyme
- Luxembourg · Pulmozyme
- Latvia · Pulmozyme
- Netherlands · Pulmozyme Verneveloplossing
- Norway · Pulmozyme
- Poland · Pulmozyme
- Portugal · Pulmozyme
- Romania · Pulmozyme
- Slovenia · Pulmozyme
- Slovakia · Pulmozyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e45b6a7d-0a2a-43a2-b09a-8ca1d58b7665 GET /v1/drugs/e45b6a7d-0a2a-43a2-b09a-8ca1d58b7665?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20140716000049",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140716000049",
"product_doc_link": "https://docetp.mpa.se/LMF/Pulmozyme%201%20mg%20per%20ml%20nebuliser%20solution%20CZ%20PL_09001bee807a7e2a.pdf"
}See everything about dornase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.